Delivery Order SPE2DB22D3016-SPE2DB25FBDA7
- Not listed
- The Defense Logistics Agency awarded a $13,496.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (10 mL) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a delivery order under a larger indefinite delivery vehicle, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $18,736.79 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-competitive delivery order was issued on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,836.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This non-set-aside, competitively awarded contract represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,513.01 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This contract represents a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product, with a ceiling value of $4,317.62 and an ultimate completion date of July 15, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $27,708.84 to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded a $45,117.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product, with an ultimate completion date of June 26, 2025. The contract was awarded on a firm fixed-price basis with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,581.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, which must be completed by June 20, 2025, represents a small-value procurement from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TYPHIM VI (typhoid vaccine) 25 mcg/0.5 mL syringes valued at $55,192.00 on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a small transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,485.75 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDA7Delivery Order
The Defense Logistics Agency awarded a $1,210.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 mcg/0.5 mL vial (10 mL). This is a non-set-aside competitively awarded contract with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company holds significant contract authority to distribute a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains through its DLA framework agreement. This specific delivery order for typhoid vaccine supports the Defense Health Agency's medical supply requirements and reflects AmerisourceBergen's ongoing role as a primary pharmaceutical supplier for Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/25/25 |